C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile
C. Michael Gibson MD

@cmichaelgibson

Non-Profit Founder/Leader | ❤️ Doc | Artist Scientist Educator | News Anchor clinicaltrialresults.org | RT ≠ endorse | Disclaimer: bit.ly/1mewZOF

ID: 879161563

linkhttp://www.linkedin.com/in/cmichaelgibson calendar_today14-10-2012 02:33:11

85,85K Tweet

437,437K Takipçi

372,372K Takip Edilen

C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo
C. Michael Gibson MD
@cmichaelgibson

20 days ago

OCEANIC-AF trial shows factor XI inhibitor asundexian was inferior for preventing stroke and systemic embolism vs. apixaban in pts with Afib and high stroke risk. Trial stopped early due to inferiority of asunxdexian. #ESCCongress

OCEANIC-AF trial shows factor XI inhibitor asundexian was inferior for preventing stroke and systemic embolism vs. apixaban in pts with Afib and high stroke risk. Trial stopped early due to inferiority of asunxdexian. #ESCCongress